BSI, a Delaware Corporation has a proprietary R&D platform for truly sustainable and improved production of consistent and high- quality Advanced Botanical Materials (ABM). ABM-01 is the first ABM produced by the company, based on a tissue cultured plant called Quillaja saponaria. ABM-01 is the active ingredient used in two gold standard products, BSI’s biopesticide Quillibrium® and the adjuvant QS-21, used in modern vaccine development. To learn more visit us at https://botanical-solution.com/.

Authors

Gaston Salinas

Co founder and CEO at Botanical Solution Inc.

Salinas is an Industrial Engineer that has passionately built his professional career around science-based ventures and corporate innovation. The knowledge and practice acquired after ten years in ...

❮ ❯

Interviews

29577

Revolutionizing Vaccine Adjuvants: A Journey with ...

27421

Untapping the potential of saponin based vaccine a...